Jingnan Shen, MD

leader
Department of Musculoskeletal Oncology Center, The First Affiliated Hospital of Sun Yat-sen University, China (People's Republic)

 Professor Jingnan Shen is the leader of Dept. of Musculoskeletal Oncology, first affiliated hospital, Sun Yatsen University, Guangzhou, P.R.China.
 engaged in the clinical and basic transformation research of the multidisciplinary diagnosis and treatment of bone tumors.
 good at the diagnosis and limb salvage of malignant bone tumors, especially pediatric bone tumors, and resection and reconstruction of pelvic and spinal tumors.
 presided over 20 national and provincial natural science research funds.
published more than 80 papers on the pathogenesis and metastasis mechanism of osteosarcoma in the international oncology journals, such as Nat Cell Biol, J Natl Cancer Inst, J Clin Invest, Clin Cancer Res and Oncogene.

Poster(s):

• (P 168) A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PEXIDARTINIB IN ASIAN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR

• (P 169) UPDATED EFFICACY AND SAFETY PROFILE OF PIMICOTINIB (ABSK021) IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): 1-YEAR FOLLOW-UP FROM PHASE 1B

• (P 543) MANEUVER STUDY: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF PIMICOTINIB (ABSK021) TO ASSESS THE EFFICACY AND SAFETY IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR